"Lymphocyte Count" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The number of LYMPHOCYTES per unit volume of BLOOD.
| Descriptor ID |
D018655
|
| MeSH Number(s) |
E01.370.225.500.195.107.595.500 E01.370.225.625.107.595.500 E05.200.500.195.107.595.500 E05.200.625.107.595.500 E05.242.195.107.595.500 G04.140.107.595.500 G09.188.105.595.500
|
| Concept/Terms |
Lymphocyte Count- Lymphocyte Count
- Lymphocyte Counts
- Lymphocyte Number
- Lymphocyte Numbers
- Total Lymphocyte Count
- Lymphocyte Count, Total
- Lymphocyte Counts, Total
- Total Lymphocyte Counts
|
Below are MeSH descriptors whose meaning is more general than "Lymphocyte Count".
Below are MeSH descriptors whose meaning is more specific than "Lymphocyte Count".
This graph shows the total number of publications written about "Lymphocyte Count" by people in this website by year, and whether "Lymphocyte Count" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 3 | 3 |
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2016 | 0 | 7 | 7 |
| 2017 | 8 | 57 | 65 |
| 2018 | 4 | 49 | 53 |
| 2019 | 2 | 17 | 19 |
| 2020 | 1 | 96 | 97 |
| 2021 | 1 | 63 | 64 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphocyte Count" by people in Profiles.
-
H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice. Emerg Microbes Infect. 2021 Dec; 10(1):1156-1168.
-
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Emerg Microbes Infect. 2021 Dec; 10(1):905-912.
-
COVID-19 disease in hospitalized young adults in India and China: Evaluation of risk factors predicting progression across two major ethnic groups. J Med Virol. 2022 01; 94(1):272-278.
-
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity. Eur J Immunol. 2021 10; 51(10):2478-2484.
-
Disruption of the biological activity of protease-activated receptors2/4 in adults rather than children in SARS CoV-2 virus-mediated mortality in COVID-19 infection. Drug Dev Res. 2021 12; 82(8):1075-1078.
-
Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J Med Virol. 2022 01; 94(1):211-221.
-
The effect of smoking on COVID-19-linked biomarkers in hospitalized patients with COVID-19. J Clin Lab Anal. 2021 Oct; 35(10):e23983.
-
Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19. Clin Transl Sci. 2021 11; 14(6):2556-2565.
-
Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination. J Med Virol. 2022 01; 94(1):14-16.
-
Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease. Immunol Res. 2021 12; 69(6):576-583.